Zobrazeno 1 - 10
of 53
pro vyhledávání: '"HIV-1 therapy"'
Autor:
Jyotsna Jai, Deborah Shirleen, Christian Hanbali, Pamela Wijaya, Theresia Brigita Anginan, William Husada, Muhammad Yogi Pratama
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract The spread of HIV is on the rise and has become a global issue, especially for underdeveloped and developing countries. This is due to the fact that HIV majorly occurs asymptomatically and is implausible for early diagnosis. Recent advances
Externí odkaz:
https://doaj.org/article/131bd07847e64120819a879546a4d4e0
Publikováno v:
Virology Journal, Vol 19, Iss 1, Pp 1-15 (2022)
Abstract The recently published AMP trial (HVTN 703/HPTN 081 and HVTN704/HPTN 085) results have validated broad neutralising antibodies (bNAbs) as potential anti-HIV-1 agents. However, single bNAb preparations are unlikely to cope with the onslaught
Externí odkaz:
https://doaj.org/article/411fa744bd4346af8b3ce3776a0f721f
Publikováno v:
Retrovirology, Vol 16, Iss 1, Pp 1-12 (2019)
Abstract The existing repertoire of HIV-1 patient derived broadly neutralising antibodies (bNAbs) that target the HIV-1 envelope glycoprotein (Env) present numerous and exciting opportunities for immune-based therapeutic and preventative strategies a
Externí odkaz:
https://doaj.org/article/b98507aa6b744044ac4e266a91503950
Publikováno v:
Viruses, Vol 5, Iss 11, Pp 2748-2766 (2013)
Despite the great success of highly active antiretroviral therapy (HAART) in ameliorating the course of HIV infection, alternative therapeutic approaches are being pursued because of practical problems associated with life-long therapy. The eradicati
Externí odkaz:
https://doaj.org/article/0d982160fc3d4eda99b032d5d02b9e68
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Retrovirology, Vol 16, Iss 1, Pp 1-12 (2019)
Retrovirology
Retrovirology
The existing repertoire of HIV-1 patient derived broadly neutralising antibodies (bNAbs) that target the HIV-1 envelope glycoprotein (Env) present numerous and exciting opportunities for immune-based therapeutic and preventative strategies against HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93ab8b044c647e6fe1278710f477259
http://link.springer.com/article/10.1186/s12977-019-0493-y
http://link.springer.com/article/10.1186/s12977-019-0493-y
Autor:
Guohua Yi, Jang Gi Choi, Preeti Bharaj, Sojan Abraham, Ying Dang, Tal Kafri, Ogechika Alozie, Manjunath N Manjunath, Premlata Shankar
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 3, Iss C (2014)
CCR5 disruption by zinc finger nucleases (ZFNs) is a promising method for HIV-1 gene therapy. However, successful clinical translation of this strategy necessitates the development of a safe and effective method for delivery into relevant cells. We u
Externí odkaz:
https://doaj.org/article/43552941e81f4adfa9ff5d55724fa5de
The emergence of drug resistance is a serious threat to the long-term virologic success and durability of HIV-1 therapy. Adherence has been shown to be a major determinant of drug resistance; however, each pharmacologic class of antiretroviral drugs
Externí odkaz:
http://hdl.handle.net/10393/42202
Publikováno v:
Bioscience Reports
HIV-1 nucleocapsid (NC) becomes an attractive target for the development of novel anti-HIV-1 agents. Discovering of non-antibody scaffolds that disrupt the function of NC will be a potential aspect for disturbing viral maturation process. Correspondi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9039a23594356f3ff75f754b15822ceb
http://europepmc.org/articles/PMC7313444
http://europepmc.org/articles/PMC7313444
Autor:
Chaves, Mariana Duarte Tovar
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2019 Made available in DSpace on 2020-05-04T22:59:10Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-09-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::1ebbb60a0b6eb13f353a531713a0f47a